Document Detail


Treatment vault shielding for a flattening filter-free medical linear accelerator.
MedLine Citation:
PMID:  19190359     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The requirements for shielding a treatment vault with a Varian Clinac 2100 medical linear accelerator operated both with and without the flattening filter were assessed. Basic shielding parameters, such as primary beam tenth-value layers (TVLs), patient scatter fractions, and wall scatter fractions, were calculated using Monte Carlo simulations of 6, 10 and 18 MV beams. Relative integral target current requirements were determined from treatment planning studies of several disease sites with, and without, the flattening filter. The flattened beam shielding data were compared to data published in NCRP Report No. 151, and the unflattened beam shielding data were presented relative to the NCRP data. Finally, the shielding requirements for a typical treatment vault were determined for a single-energy (6 MV) linac and a dual-energy (6 MV/18 MV) linac. With the exception of large-angle patient scatter fractions and wall scatter fractions, the vault shielding parameters were reduced when the flattening filter was removed. Much of this reduction was consistent with the reduced average energy of the FFF beams. Primary beam TVLs were reduced by 12%, on average, and small-angle scatter fractions were reduced by up to 30%. Head leakage was markedly reduced because less integral target current was required to deliver the target dose. For the treatment vault examined in the current study, removal of the flattening filter reduced the required thickness of the primary and secondary barriers by 10-20%, corresponding to 18 m(3) less concrete to shield the single-energy linac and 36 m(3) less concrete to shield the dual-energy linac. Thus, a shielding advantage was found when the linac was operated without the flattening filter. This translates into a reduction in occupational exposure and/or the cost and space of shielding.
Authors:
Stephen F Kry; Rebecca M Howell; Jerimy Polf; Radhe Mohan; Oleg N Vassiliev
Related Documents :
15369419 - Pharmacoeconomic challenges in the management of diabetic nephropathy.
8202289 - Amputations in the surgical budget.
16187699 - The impact of losartan on the lifetime incidence of esrd and costs in mexico.
3780159 - Evaluation of intravascular low-osmolality contrast agents.
17494889 - Hospital protocols for targeted glycemic control: development, implementation, and mode...
18623119 - Finding blunders in thyroid testing: experience in newborns.
15043959 - European nicotinamide diabetes intervention trial (endit): a randomised controlled tria...
16384859 - Cloning of rainbow trout slc26a1: involvement in renal sulfate secretion.
9833939 - Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopau...
Publication Detail:
Type:  Journal Article     Date:  2009-02-03
Journal Detail:
Title:  Physics in medicine and biology     Volume:  54     ISSN:  0031-9155     ISO Abbreviation:  Phys Med Biol     Publication Date:  2009 Mar 
Date Detail:
Created Date:  2009-02-10     Completed Date:  2009-06-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401220     Medline TA:  Phys Med Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  1265-73     Citation Subset:  IM    
Affiliation:
Department of Radiation Physics, The University of Texas M.D Anderson Cancer Center, Houston, TX, USA. sfkry@mdanderson.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Particle Accelerators*
Radiation Protection / methods*
Radiotherapy Planning, Computer-Assisted*
Scattering, Radiation

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Web 3D for public, environmental and occupational health: early examples from second life.
Next Document:  A high-sensitivity small animal SPECT system.